Management of Iron Deficiency Anemia in a 66-Year-Old Male
For a 66-year-old male with iron deficiency anemia, you must perform bidirectional endoscopy (gastroscopy and colonoscopy) as first-line investigation to identify gastrointestinal bleeding sources, while simultaneously initiating oral iron replacement therapy without delay. 1, 2
Diagnostic Workup
Essential Initial Testing
- Confirm IDA diagnosis: Ferritin <30 ng/mL (in absence of inflammation) or transferrin saturation <20% 3
- Immediate investigations (do not delay iron therapy while awaiting these):
Critical Context for Men
In men and postmenopausal women, IDA is caused by gastrointestinal blood loss or malabsorption until proven otherwise 4, 6. The most common sources include:
- Colon cancer (7 times more common than upper GI malignancy) 4
- Gastric/duodenal ulcers
- Angiodysplasia
- Atrophic gastritis causing malabsorption 3
If Initial Workup is Negative
Only pursue further investigation if:
- Inadequate response to iron replacement therapy after 2-4 weeks, OR
- Recurrent IDA after initial correction 2
Then proceed with:
- Capsule endoscopy (preferred for small bowel evaluation) 1, 2
- CT/MR enterography as complementary imaging 2
- Renal tract evaluation 2
Iron Replacement Therapy
First-Line: Oral Iron
Start immediately—do not wait for endoscopy results unless colonoscopy is scheduled within days 2
Optimal regimen:
- Ferrous sulfate 200 mg (65 mg elemental iron) once daily 2
- Take on empty stomach for maximum absorption 2
- Add vitamin C supplementation to enhance absorption 1
Alternative if not tolerated:
- Reduce to alternate-day dosing (same tablet, every other day) 2
- Switch to ferric maltol (though more expensive) 2
- Consider ferrous fumarate or gluconate 2
Common pitfall: Do NOT switch between different traditional iron salts (ferrous sulfate/fumarate/gluconate) for intolerance—this is not evidence-based. Instead, try alternate-day dosing or move to IV iron 2
Monitoring Response
- Check hemoglobin at 2 weeks: Failure to rise by ≥10 g/L predicts treatment failure (90% sensitivity) 2
- Continue monitoring every 4 weeks until hemoglobin normalizes 2
- After hemoglobin normalizes, continue oral iron for 3 months to replenish iron stores 2
Indications for Intravenous Iron
- Oral iron not tolerated despite dose adjustment
- Ferritin fails to improve after adequate oral iron trial
- Malabsorption conditions identified (celiac disease, atrophic gastritis, post-bariatric surgery)
- Ongoing bleeding with inadequate oral response
- Chronic inflammatory conditions (if discovered)
IV iron formulation preference:
- Use preparations requiring 1-2 infusions rather than multiple doses 1
- All IV iron formulations have similar safety profiles 1
- True anaphylaxis is very rare; most reactions are complement activation-related pseudo-allergy (infusion reactions) 1
Special Considerations for This Patient
Age-Related Factors
At 66 years old, this patient has higher risk for:
- Gastrointestinal malignancy (making endoscopy mandatory)
- Angiodysplasia as bleeding source
- Multiple simultaneous causes of anemia 7
- Atrophic gastritis causing malabsorption
If Endoscopy Reveals Specific Lesions
- Angiodysplasia: Treat endoscopically with argon plasma coagulation or hemostatic clips, plus continue iron replacement 1
- Gastric antral vascular ectasia (GAVE): Endoscopic band ligation or thermal therapy if inadequate response to iron 1
- Portal hypertensive gastropathy: Start with oral iron; add nonselective β-blockers if no other bleeding source 1
Long-Term Management
- After correction, monitor CBC every 6 months initially to detect recurrence 2
- If IDA recurs with negative comprehensive workup, long-term maintenance iron therapy is appropriate 2
- Repeat investigations only if ongoing IDA despite adequate iron replacement 1, 2
Blood Transfusion
Rarely indicated unless severe symptomatic anemia with circulatory compromise 2. If needed: